3362.0 Adverse Drug Reactions: Extent of Public Health Risks

Monday, October 31, 2011: 2:30 PM
Oral
According to a new book, The Risks of Prescription Drugs, they have become a major public health problem because of 2.5 million serious adverse drug reactions a year, 1.5 hospitalizations, and about 129,000 deaths. APHA members need to understand the causes and extent of the problem and ways to increase safer, more effective drugs. This session is relevant to Medical Care, Epidemiology, and Public Health Policy. Leading figures will present.
Session Objectives: 1. Describe the extent of adverse drug reactions as a public health danger in the United States 2. Explain why most new drugs are little better for patients than existing ones yet bear under-tested risks of harmful side effects. 3. Understand ways to reduce the epidemic in harmful side effects.
Organizer:
Donald Light, MA, PhD
Moderator:
John D. Abramson, MD

2:30 PM
Scope of Adverse Drug Reactions and Challenges
Donald Light, PhD
     
2:45 PM
Antipsychotic Medication Use in Community-based Youth: Trends and Implications for Improving Drug Safety
Julie M. Zito, PhD, MS
     
3:00 PM
Patents and Inverse Benefit from Drugs
Howard Brody, MD PhD
3:15 PM
S. 1137, The Medical Innovation Prize Fund Act: How De-linking R&D Incentives from Prices Will Deliver Safer, More Effective Drugs at Significantly Lower Prices
Bernard Sanders, US Senator
3:30 PM
Market Failure in Medical Knowledge: Harming Patients by Systematic Misrepresentation of the Benefits and Risks of New Drugs
John D. Abramson, MD
     
  

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Medical Care

See more of: Medical Care
<< Previous Session | Next Session >>